CD International Enterprises (CDII) Positioned for Growth on CD International Enterprises (CDII) Positioned for Growth on Expanding CBD Market Due to Unique Target Audience
- Company targeting unique global market of more than two billion people in Chinese-speaking communities
- New CBD subsidiary key to CD International Enterprises’ expansion process
- CBD market expected to grow 700 percent to over $2 billion by 2020
Much like the overall marijuana industry, the cannabidiol (CBD) market is growing exponentially, due primarily to the extract’s versatility and wide range of possible uses in the pharmaceutical world. CD International Enterprises, Inc. (OTC: CDII), a complex company that provides corporate consulting services and industrial commodities, recently entered the CBD sector and is already carving a niche out for itself by targeting a unique market of more than two billion people: Chinese-speaking communities in the United States and around the world.
According to a recent report by The Hemp Business Journal (https://dtn.fm/2G1cG), the CBD market is expected to grow to $2.1 billion by 2020. This would mark a massive 700 percent increase from last year’s market of $202 million. The figure is impressive, but other industry experts are even more optimistic. Greenware Advisors’ Matt Karnes believes the CBD market size could reach $3 billion by 2021, according to Forbes (https://dtn.fm/3mzHQ). His prediction is largely based on the fact that CBD is allowed in areas that haven’t yet legalized marijuana.
One of the 85+ cannabinoids identified so far in cannabis and hemp, CBD possesses multiple therapeutic benefits, making it an essential component for drug manufacturing efforts targeting a wide range of medical conditions, including epilepsy, diabetes, Alzheimer’s disease, anxiety, liver disease, and many more. Unlike the more famous cannabis compound tetrahydrocannabinol (THC) that’s used for recreational purposes, CBD does not have a psychoactive effect.
The similarity between this natural extract with its many uses and traditional Chinese medicine has created a significant opportunity for CBD-based products in Chinese-speaking markets, an opportunity that CD International Enterprises has promptly seized. In April, the company launched a special division tasked with the distribution of bulk cannabidiol crystal in the United States and CBD-based products to Chinese-speaking communities. The new subsidiary, Green Products Distribution, joins CD International Enterprises’ mineral trading and business consulting divisions and is expected to help bring the company significant exposure and revenue on the fast-growing marijuana market.
Green Products Distribution and the associated Chinese language online store are a key part of the company’s current expansion plans. Under the leadership of Dr. James Wang, a seasoned executive who has worked with various technology and pharmaceutical corporations over the years, and with the work of its dedicated, culturally diverse team, CD International Enterprises is set for consistent growth in its niche, having plans to rapidly expand its CBD distribution services to Chinese-speaking communities all over the world. A mobile application for optimal distribution of cannabidiol products is also under development and will be made available to Green Products Distribution customers.
Additionally, the company is sourcing several different CBD products in the U.S., with plans to enter distribution agreement for them, as well as to begin distribution of such products via traditional Chinese medicine stores and retail pharmaceutical chains in China. This would significantly expand the number of business opportunities in Chinese-speaking markets all over the world, allowing CD International Enterprises to become an uncontested leader in its niche.
For more information, visit the company’s website at www.CDII.net
Please see disclaimer on the QualityStocks website: https://Disclaimer.QualityStocks.com